Sino Biological has announced the construction of its new bioprocessing center in the United States

Sino Biological, Inc. is pleased (“Sino Biological” or the “Company”), a biotechnology company listed on the Shenzhen Stock Exchange (SZSE: 301047), which provides biological research reagents and research services related to technical contracts, announces the formal signing of a lease agreement with Hines and commence construction of its new Bioprocessing Center (C4B) at the Levit Green facility in Houston, Texas, USA.

Headquartered in Beijing, China with subsidiaries in Suzhou, China; Taizhou, China; Frankfurt, Germany; Kawasaki, Japan; Wuwen, PA, and listed on Shenzhen subsidiary ChiNext (SZSE: 301047), Sino Biological is a leading global provider of mammalian cell-based recombinant proteins, antibodies, and related contract research services. This new location serves as the company’s first US-based manufacturing facility. Referred to as the Center for Bioprocessing (C4B), the facility will focus on both manufacturing products and performing contract research services. Levit Green will solidify its presence in Houston, providing businesses, academics, and medical researchers at the world-renowned Texas Medical Center and throughout the region invaluable access to Sino Biological’s comprehensive offering of Bioreagents and CRO services.

We are very excited about our new partnership with the Hines team and our upcoming lab and production facility in Levit Green. Hines is at the forefront of designing and developing next-generation lab spaces, and our new location in the Levit Green masterplan in the heart of Houston’s Texas Medical Center will enable Sino Biological to significantly expand its research services and biomanufacturing capabilities into the United States.”

Dr.. Rob Burgess, Chief Business Officer, Sino Biological

“I am excited to develop the Bioprocessing Center in Houston. I strongly believe in excellent science and cutting-edge technologies, which is why I joined Sino Biological. I have assembled a world-class team that is currently creating C4B with the ultimate goal of advancing the scientific development of the next generation of precise therapeutic antibodies and proteins,” he states. So Dr. Yingmin Zhou, president of C4B.

“Levit Green has been meticulously designed to provide a best-in-class life sciences space that can accommodate a multitude of uses. Welcoming Sino Biological is a testament to the market need for a sophisticated, flexible space that allows diverse companies to conduct a variety of research,” said John Moose, Director Hines Senior Administrator. “Sino Biological is an excellent addition to the region’s growing life sciences ecosystem, and we look forward to supporting its continued growth and success.”